Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million
Go back to Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million| (NASDAQ: VRDN) | Delayed: 17.63 +1.00 (6.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.63 | 52 Week High | $ | |||
| Open | $16.93 | 52 Week Low | $ | |||
| Day High | $18.18 | P/E | N/A | |||
| Day Low | $16.93 | EPS | $ | |||
| Volume | 2,549,627 | |||||
